top of page
brainSideView.png

Development of
an improved hydrocephalus shunt

CSF-Dynamics is developing a new type of hydrocephalus shunt that overcomes the major issues of current shunts on the market. The shunt is currently undergoing clinical testing. CSF-Dynamics expects the shunt to be approved for clinical use by 2027.

CSF-Dynamics received a Horizon 2020 Phase 2 SME grant (849502) from the European Commission to support our clinical pilot study. We are now planning a larger Pivotal Study in 5 countries.

Please contact us by email if you are interested to know more about the technology and the status of the development.

Article1.png

Clinical results:
JNS article

After several years of research and technological development at CSF-Dynamics we can now present the results of the pilot study on our novel CSF-shunting device.  This method of shunting to the intracranial sinus for the treatment of hydrocephalus is intended to significantly reduce both revisions and complications by mimicking physiological drainage. We would like to thank Dr Sune Munthe and his team at Odense University Hospital for supporting us in this investigation and showing that our shunt remains patent and avoids overdrainage. We are convinced that this method has a future in the standard of care and will move forwards to plan a larger international study as soon as possible.

The abstract can be found on the Journal of Neurosurgery.

NEWS: Please follow us on LinkedIn

LinkedIN.png

#EANS2022, Belgrade

Sune Munthe MD, PhD, neurosurgeon, Odense University Hospital, Denmark presented the promissing final results of the clinical pilot study at the European neurosurgical congress at Crowne Plaza Belgrade, Serbia.

#Hydrocephalus2022

Sune Munthe MD, PhD, neurosurgeon, Odense University Hospital, Denmark presented the very promising final results of the clinical pilot study at the fourteenth meeting of the Hydrocephalus Society in Gothenburg, Sweden, 10 September 2022.

#SNS2022, Bergen

The preliminary results of the clinical pilot study was presented at annual meeting of Scandinavian Neurosurgical Society (SNS) by Sune Munthe MD, PhD, neurosurgeon, Odense University Hospital, Denmark, on Sunday 15 May 2022 at Radisson Blu, Bergen, Norway. Svend Erik Børgesen, MD (Chief Clinical Officer, CSF-Dynamics) was also present at the session to answer the questions and comments from the audience.

#AANS2022, USA

The first preliminary results of the clinical pilot study was presented at AANS by Mikkel Andersen MD, neurosurgeon, Odense University Hospital, Denmark, 2 May 2022 at AANS, Pennsylvania Convention Center.

bottom of page